BVS
Bioventus Inc. Class A Common StockData: 2026-09-11
Quick Stats
Sep 11, 202646.0
AI Score
HOLD0.58
Volume Ratio
Nov 03, 2026
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
BVS Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
BVS Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
BVS Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BVS Daily Out of Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BVS Daily In the Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BVS Most Active Options by Volume(near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BVS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BVS Stock Summary
Last updated Sep 11, 2026
BVS is currently trading at $12.98, positioned above its 200-day moving average of $9.84, indicating a long-term uptrend. The stock has a 52-week range of $6.255 to $15.8927.
Technical Analysis: The 50-day moving average stands at $13.17, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.271, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.034, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates BVS at 46.0/100 with a HOLD recommendation.
BVS (Bioventus Inc. Class A Common Stock) Indicators
Last updated Sep 11, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 41.271 |
| CMF (20) | 0.034 |
| ROC (10) | -5.874 |
| ADX (14) | 29.564 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.083 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -96.319 |
| MFI (14) | 26.866 |
BVS Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Sep 10 | Marubozu (bearish) (contrarian — textbook says the opposite) | Bullish | 56.2% | +3.2 pts | 30540 |
| Aug 28 | Tristar (bullish) | Bullish | 57.5% | +4.5 pts | 1015 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Bioventus Inc. Class A Common Stock is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).
BVS Moving Averages Analysis
Bioventus Inc. Class A Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 11, 2026
BVS (Bioventus Inc. Class A Common Stock) Simple Moving Averages
Moving Averages are last updated Sep 11, 2026
| Days | MA |
|---|---|
| 10 | 13.75 |
| 20 | 13.96 |
| 30 | 13.94 |
| 50 | 13.17 |
| 100 | 11.36 |
| 200 | 9.84 |
BVS Fundamental Analysis
| P/E (Forward) | 14.8148 |
| P/E (Trailing) | 17.4133 |
| Market Cap ($) | 892.1 million |
| Earnings/Share ($) | 0.75 |
| Net Profit Margin (%) | 0.0936 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.778 |
| EPS Estimate Next Year ($) | 0.92 |
| WallStreet Target Price ($) | 17.60 |
| Most Recent Quarter |
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.